GT200500111A - ACID 2 - {[2- (2-METHYLAMINOPIRIMIDIN-4-IL) -1H-INDOL-5-CARBONIL] AMINO} -3-PHENYLPIRIDIN-2-ILAMINO) SUBSTANTIALLY PURE PROPIONIC AS IKB KINASE INHIBITOR - Google Patents

ACID 2 - {[2- (2-METHYLAMINOPIRIMIDIN-4-IL) -1H-INDOL-5-CARBONIL] AMINO} -3-PHENYLPIRIDIN-2-ILAMINO) SUBSTANTIALLY PURE PROPIONIC AS IKB KINASE INHIBITOR

Info

Publication number
GT200500111A
GT200500111A GT200500111A GT200500111A GT200500111A GT 200500111 A GT200500111 A GT 200500111A GT 200500111 A GT200500111 A GT 200500111A GT 200500111 A GT200500111 A GT 200500111A GT 200500111 A GT200500111 A GT 200500111A
Authority
GT
Guatemala
Prior art keywords
substantially pure
phenylpiridin
methylaminopirimidin
carbonil
ilamino
Prior art date
Application number
GT200500111A
Other languages
Spanish (es)
Inventor
El-Bdaoui Haddad
Olaf Ritzeler
David J Aldous
Paul Joseph Cox
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT200500111A publication Critical patent/GT200500111A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • AIDS & HIV (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

LA PRESENTE INVENCION ESTA DIRIGIDA AL COMPUESTO SUSTANCIALMENTE PURO DE FORMULA (A), O UNA SAL FARMACEUTICAMENTE ACEPTABLE, O SOLVATO DE DICHO COMPUESTO; A UNA COMPOSICION FARMACEUTICA QUE COMPRENDE UNA CANTIDAD FARMACEUTICAMENTE EFICAZ DEL COMPUESTO DE FORMULA (A), Y UN VEHICULO FARMACEUTICAMENTE ACEPTABLE; Y AL USO DE UN COMPUESTO DE FORMULA (A) QUE TIENE ACTIVIDAD COMO INHIBIDOR, PREFERIBLEMENTE UN INHIBIDOR SELECTIVO, DE IKB (IKK), EN PARTICULAR IKK2, Y A METODOS RELACIONADOS CON ELLO. T2005THIS INVENTION IS DIRECTED TO THE SUBSTANTIALLY PURE COMPOUND OF FORMULA (A), OR A PHARMACEUTICALLY ACCEPTABLE SALT, OR SOLVATE OF SUCH COMPOUND; TO A PHARMACEUTICAL COMPOSITION THAT INCLUDES A PHARMACEUTICALLY EFFECTIVE AMOUNT OF THE FORMULA COMPOUND (A), AND A PHARMACEUTICALLY ACCEPTABLE VEHICLE; AND TO THE USE OF A FORMULA COMPOUND (A) THAT HAS ACTIVITY AS AN INHIBITOR, PREFERIBLY A SELECTIVE INHIBITOR, OF IKB (IKK), IN PARTICULAR IKK2, AND TO METHODS RELATED TO IT. T2005

GT200500111A 2004-05-12 2005-05-11 ACID 2 - {[2- (2-METHYLAMINOPIRIMIDIN-4-IL) -1H-INDOL-5-CARBONIL] AMINO} -3-PHENYLPIRIDIN-2-ILAMINO) SUBSTANTIALLY PURE PROPIONIC AS IKB KINASE INHIBITOR GT200500111A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57014604P 2004-05-12 2004-05-12

Publications (1)

Publication Number Publication Date
GT200500111A true GT200500111A (en) 2006-05-09

Family

ID=34969825

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200500111A GT200500111A (en) 2004-05-12 2005-05-11 ACID 2 - {[2- (2-METHYLAMINOPIRIMIDIN-4-IL) -1H-INDOL-5-CARBONIL] AMINO} -3-PHENYLPIRIDIN-2-ILAMINO) SUBSTANTIALLY PURE PROPIONIC AS IKB KINASE INHIBITOR

Country Status (23)

Country Link
EP (1) EP1747215A1 (en)
JP (1) JP2007537266A (en)
KR (1) KR20070011483A (en)
CN (1) CN1950359A (en)
AR (1) AR049274A1 (en)
AU (1) AU2005245834A1 (en)
BR (1) BRPI0511029A (en)
CA (1) CA2566213A1 (en)
EC (1) ECSP066992A (en)
GT (1) GT200500111A (en)
IL (1) IL178992A0 (en)
MA (1) MA28553B1 (en)
MX (1) MXPA06012870A (en)
NO (1) NO20065719L (en)
PA (1) PA8633101A1 (en)
PE (1) PE20060269A1 (en)
RU (1) RU2006143758A (en)
SV (1) SV2006002111A (en)
TN (1) TNSN06338A1 (en)
TW (1) TW200605881A (en)
UY (1) UY28897A1 (en)
WO (1) WO2005113544A1 (en)
ZA (1) ZA200608712B (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19951360A1 (en) 1999-10-26 2001-05-03 Aventis Pharma Gmbh Substituted indoles
DE102004033406A1 (en) 2004-07-10 2006-02-16 Sanofi-Aventis Deutschland Gmbh Process for the preparation of the enantiomeric forms of 2,3-diaminopropionic acid derivatives
EP2025674A1 (en) 2007-08-15 2009-02-18 sanofi-aventis Substituted tetra hydro naphthalines, method for their manufacture and their use as drugs
EP2278999A4 (en) 2008-04-21 2015-04-22 Otonomy Inc Auris formulations for treating otic diseases and conditions
US11969501B2 (en) 2008-04-21 2024-04-30 Dompé Farmaceutici S.P.A. Auris formulations for treating otic diseases and conditions
WO2011107494A1 (en) 2010-03-03 2011-09-09 Sanofi Novel aromatic glycoside derivatives, medicaments containing said compounds, and the use thereof
MY159995A (en) * 2010-04-27 2017-02-15 Hutchison Medipharma Ltd Pyrimidinyl indole compounds
US8933024B2 (en) 2010-06-18 2015-01-13 Sanofi Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
WO2012120053A1 (en) 2011-03-08 2012-09-13 Sanofi Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
WO2012120056A1 (en) 2011-03-08 2012-09-13 Sanofi Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
US8828994B2 (en) 2011-03-08 2014-09-09 Sanofi Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
WO2012120055A1 (en) 2011-03-08 2012-09-13 Sanofi Di- and tri-substituted oxathiazine derivates, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
US8901114B2 (en) 2011-03-08 2014-12-02 Sanofi Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof
EP2760862B1 (en) 2011-09-27 2015-10-21 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2018005830A1 (en) 2016-06-29 2018-01-04 Otonomy, Inc. Triglyceride otic formulations and uses thereof
CN106588803A (en) * 2016-11-16 2017-04-26 西南科技大学 Novel method for preparing 5-acetylisoxazole

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10237722A1 (en) * 2002-08-17 2004-08-19 Aventis Pharma Deutschland Gmbh Indole or benzimidazole derivatives for the modulation of IKappaB kinase

Also Published As

Publication number Publication date
MA28553B1 (en) 2007-04-03
TW200605881A (en) 2006-02-16
TNSN06338A1 (en) 2008-02-22
AR049274A1 (en) 2006-07-12
PE20060269A1 (en) 2006-05-11
IL178992A0 (en) 2007-03-08
ZA200608712B (en) 2008-06-25
KR20070011483A (en) 2007-01-24
JP2007537266A (en) 2007-12-20
AU2005245834A1 (en) 2005-12-01
RU2006143758A (en) 2008-06-27
MXPA06012870A (en) 2007-02-15
EP1747215A1 (en) 2007-01-31
UY28897A1 (en) 2005-12-30
BRPI0511029A (en) 2007-11-27
CN1950359A (en) 2007-04-18
CA2566213A1 (en) 2005-12-11
PA8633101A1 (en) 2006-01-23
NO20065719L (en) 2006-12-12
SV2006002111A (en) 2006-01-30
WO2005113544A1 (en) 2005-12-01
ECSP066992A (en) 2006-12-29

Similar Documents

Publication Publication Date Title
GT200500111A (en) ACID 2 - {[2- (2-METHYLAMINOPIRIMIDIN-4-IL) -1H-INDOL-5-CARBONIL] AMINO} -3-PHENYLPIRIDIN-2-ILAMINO) SUBSTANTIALLY PURE PROPIONIC AS IKB KINASE INHIBITOR
BRPI0507652A (en) pharmaceutical compositions comprising a benzoidiazepine derivative and an rsv fusion protein inhibitor
WO2006069155A3 (en) Inhibitors of protein arginine methyl transferases
SV2011003786A (en) CHEMICAL COMPOUNDS 251
ECSP088258A (en) SERINA PROTEASAS INHIBITORS
BRPI0507972A (en) compound, pharmaceutical composition, use of a compound, method for inhibiting the proteolytic activity of a postproline cleavage enzyme and packaged pharmaceutical composition
BRPI0507654A (en) pharmaceutical composition comprising a benzodiazepine derivative and an rsv fusion protein inhibitor
ECSP067076A (en) DERIVATIVES OF PIRIMIDINA UREA AS INHIBITORS OF QUINASA
CL2007003540A1 (en) COMPOUNDS DERIVED FROM MACROCICLES, INHIBITORS OF THE SERINE PROTEASE OF HEPATITIS C; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND FOR THE TREATMENT OF HEPATITIS C.
BRPI0507617A (en) chemokine receptor antagonists
ECSP067110A (en) DERIVATIVES OF 2-CARBAMIDA-4-FENILTIAZOL, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS
ECSP11010948A (en) INHIBITORS OF PROTEIN CINASE ENZYMES ACTIVATED BY
BRPI0518993A2 (en) compound or a pharmaceutically acceptable salt, solvate or ester thereof, pharmaceutical composition, and use of a compound
MA30725B1 (en) ADMINISTRATION OF DIPEPTIDYL PEPTIDASE INHIBITORS
CR8102A (en) DERIVATIVES OF PIRAZOLO-QUINAZOLINA, PROCEDURE FOR PREPARATION AND ITS USE AS QUINASE INHIBITORS
RS53209B (en) Pharmaceutical composition for a hepatitis c viral protease inhibitor
HN2003000044A (en) ESTERES HYDROXAMATE OF ACID N - (4-PHENYL REPLACED) -ANTRANILICO.
BRPI0617655A2 (en) compound or a pharmaceutically acceptable salt thereof, or an optical isomer thereof, use of a compound, and pharmaceutical formulation
UY30407A1 (en) DERIVATIVES OF [2,3,4,8-TETRAHYDROIMIDAZO- [1,5-A] -PIRIMIDIN-8-IL] -FENIL SUBSTITUTED SULPHONATES, PHARMACEUTICAL COMPOSITIONS AND APPLICATIONS.
AR062797A1 (en) PIPERIDINE DERIVATIVES AS RENINE INHIBITORS, PHARMACEUTICAL COMPOSITIONS.
BRPI0408353A (en) compound, pharmaceutical composition, methods for the treatment of susceptible neoplasms and for the treatment of viral infections, and, use of a compound
EA200970851A1 (en) WEEKLY INTRODUCTION OF DIPEPTIDYLPEPIDASE INHIBITORS
WO2007101710A8 (en) Use of inhibitors of scavenger receptor class proteins for the treatment of infectious diseases
CL2007003587A1 (en) COMPOUNDS DERIVED FROM SUBSTITUTED PYRIMIDINS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS AND ANOTHER ACTIVE AGENT; AND ITS USE TO TREAT OR PREVENT INFECTION OF HEPATITIS C.
DOP2006000024A (en) THIAZOLIDINONES, ITS PREPARATION AND ITS USE AS A MEDICINAL PRODUCT